Lilly Ventures

Focus on Biotech Therapeutic Companies

Program

Lilly Ventures serves as an investor and strategic partner to the global biotech ecosystem. Lilly Ventures makes investments to move the innovation needle in novel areas of science.

Event

LaunchBio, Browne Consulting, and Silicon Valley Bank, a division of First Citizens Bank, are pleased to announce their next Investor Connect virtual event with Lilly Ventures.

They deploy customized engagement models to co-invest with world-class syndicate partners and offer counsel and connections within its global network with the goal of maximizing a company’s scientific impact.

Applications will be selected based on meeting the following criteria:

Geography:
Open to investments globally

Company type:
Seed, Series A stage investments in therapeutics companies within and outside the core areas of focus for Eli Lilly and Company

Areas of Interest:

Biologics
Cell therapies
CRISPR-based therapies
Gene therapies
Protein-based therapies
Regenerative Medicine
RNA-based therapeutics
Small molecules
Vaccines

Therapeutic areas of interest include, but are not limited to:

Open to all target organs/systems and a broad range of therapeutic areas, including cardiology, endocrinology, hematology, oncology, neurology, immunology, hematology and pulmonology

Stage:
Companies seeking funding for Seed, Series A

Qualifying start-ups can apply here today.

Applications are accepted on a rolling basis. Learn more about LaunchBio’s Investor Connect series, in partnership with Browne Consulting and Silicon Valley Bank, a division of First Citizens Bank.

Bridging the gap between innovation and capital